Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€15.70

€15.70

-0.630%
-0.1
-0.630%
-
 
30.12.25 / Stuttgart Stock Exchange WKN: A1137V / Name: Theravance / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Theravance Biopharma Stock

Theravance Biopharma shows a slight decrease today, losing -€0.100 (-0.630%) compared to yesterday.

Pros and Cons of Theravance Biopharma in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Theravance Biopharma vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Theravance Biopharma -0.630% 0.000% -8.671% 74.586% 74.586% 53.398% 10.490%
Pacira Pharmaceuticals -1.820% 1.852% 10.000% 18.919% 18.919% -38.547% -53.586%
Rockwell Medical Inc. -6.560% 2.622% -15.123% -64.087% -64.087% -23.789% -91.106%
Twist Bioscience Corp -1.000% -3.029% 1.016% -39.099% -39.099% 27.402% -75.991%

News

Here's Why Shares in Theravance Biopharma Exploded Today: https://g.foolcdn.com/editorial/images/842165/gettyimages-516077862-1201x820-96628fa.jpg
Here's Why Shares in Theravance Biopharma Exploded Today

Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate

Theravance Sales Jump 83 Percent
Theravance Sales Jump 83 Percent

Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue